Accueil > Les Laboratoires > CHU de Besançon > Publications de l’équipe
Ghassani A, Triponney P, Bour M, Plésiat P, Jeannot K; MucoMicrobes study Group. Mutations in genes lpxL1, bamA, and pmrB impair the susceptibility of cystic fibrosis strains of Pseudomonas aeruginosa to murepavadin. Antimicrob Agents Chemother. 2024 Jan 10;68(1):e0129823.
Oliver A, Rojo-Molinero E, Arca-Suarez J, Be?li Y, Bogaerts P, Cantón R, Cimen C, Croughs PD, Denis O, Giske CG, Graells T, Daniel Huang TD, Iorga BI, Karatuna O, Kocsis B, Kronenberg A, López-Causapé C, Malhotra-Kumar S, Martínez LM, Mazzariol A, Meyer S, Naas T, Notermans DW, Oteo-Iglesias J, Pedersen T, Pirš M, Poeta P, Poirel L, Pournaras S, Sundsfjord A, Szabó D, Tambi?-Andraševi? A, Vatcheva-Dobrevska R, Vitkauskien? A, Jeannot K; ESGARS-ISARPAE members. Pseudomonas aeruginosa antimicrobial susceptibility profiles, resistance mechanisms and international clonal lineages: update from ESGARS-ESCMID/ISARPAE Group. Clin Microbiol Infect. 2023 Dec 30:S1198-743X(23)00634-1.
Vuillemin X, Da Silva M, Bour M, Landon C, Plésiat P, Jeannot K. Cefiderocol activity is compromised by acquired extended-spectrum oxacillinases in Pseudomonas aeruginosa. Int J Antimicrob Agents. 2023 Sep;62(3):106917.
Gaillot S, Oueslati S, Vuillemenot JB, Bour M, Iorga BI, Triponney P, Plésiat P, Bonnin RA, Naas T, Jeannot K, Potron A. Genomic characterization of an NDM-9-producing Acinetobacter baumannii clinical isolate and role of Glu152Lys substitution in the enhanced cefiderocol hydrolysis of NDM-9. Front Microbiol. 2023 Aug 28;14:1253160.
Fournier D, Triponney P, Gabriel L, Plésiat P, Jeannot K, Potron A. Evaluation of 5 rapid colorimetric and immunochromatographic tests for the detection of carbapenemases in Pseudomonas aeruginosa and Acinetobacter spp. isolates. Eur J Clin Microbiol Infect Dis. 2023 Aug;42(8):1043-1045.
Jeannot K, Gaillot S, Triponney P, Portets S, Pourchet V, Fournier D, Potron A. Performance of the Disc Diffusion Method, MTS Gradient Tests and Two Commercially Available Microdilution Tests for the Determination of Cefiderocol Susceptibility in Acinetobacter spp. Microorganisms. 2023 Jul 31;11(8):1971.
Couchot J, Fournier D, Bour M, Rajeev L, Rhodes P, Singh P, Jeannot K, Plésiat P. Evaluation of the Reveal® rapid AST system to assess the susceptibility of Pseudomonas aeruginosa from blood cultures. Eur J Clin Microbiol Infect Dis. 2023 Mar;42(3):359-363.
Anbo M, Chichkova MAT, Gençay YE, Salazar A, Jeannot K, Jelsbak L. Whole-Genome Sequencing of 11 High-Risk Clone ST111 Pseudomonas aeruginosa Isolates from French Hospitals. Microbiol Resour Announc. 2023 Jul 18;12(7):e0009123.
Vergoz D, Nilly F, Desriac F, Barreau M, Géry A, Lepetit C, Sichel F, Jeannot K, Giard JC, Garon D, Chevalier S, Muller C, Dé E, Brunel JM. 6-Polyaminosteroid Squalamine Analogues Display Antibacterial Activity against Resistant Pathogens. Int J Mol Sci. 2023 May 10;24(10):8568.
Devoos L, Biguenet A, Rousselot J, Bour M, Plésiat P, Fournier D, Jeannot K. Performance of discs, sensititre EUMDROXF microplates and MTS gradient strips for the determination of the susceptibility of multidrug-resistant Pseudomonas aeruginosa to cefiderocol. Clin Microbiol Infect. 2023 May;29(5):652.e1-652.e8.
Hoellinger B, Simand C, Jeannot K, Garijo C, Cristinar M, Reisz F, Danion F, Ursenbach A, Lefebvre N, Boyer P, Hansmann Y, Studer A, Schramm F, Ruch Y. Real-world clinical outcome of cefiderocol for treatment of multidrug-resistant non-fermenting, gram negative bacilli infections: a case series. Clin Microbiol Infect. 2023 Mar;29(3):393-395. 18. PMID: 36410645.
Cezard A, Fouquenet D, Vasseur V, Jeannot K, Launay F, Si-Tahar M, Hervé V. Poly-L-Lysine to Fight Antibiotic Resistances of Pseudomonas aeruginosa. Int J Mol Sci. 2023 Feb 2;24(3):2851.
Casanova M, Olleik H, Hdiouech S, Roblin C, Cavalier JF, Point V, Jeannot K, Caron B, Perrier J, Charriau S, Lafond M, Guillaneuf Y, Canaan S, Lefay C, Maresca M. Evaluation of the Efficiency of Random and Diblock Methacrylate-Based Amphiphilic Cationic Polymers against Major Bacterial Pathogens Associated with Cystic Fibrosis. Antibiotics (Basel). 2023 Jan 8;12(1):120.
Lupo A, Valot B, Saras E, Drapeau A, Robert M, Bour M, Haenni M, Plésiat P, Madec JY, Potron A. Multiple host colonization and differential expansion of multidrug-resistant ST25-Acinetobacter baumannii clades. Sci Rep. 2023 Dec 9;13(1):21854.
Triponney P, Bour M, Beyrouthy R, Bonnet R, Plésiat P, Jeannot K. Role of megaplasmids and chromosomal integration in acquisition of CTX-M-encoding genes by Pseudomonas aeruginosa. J Antimicrob Chemother. 2022 Oct 28;77(11):3194-3198.
Vuillemenot JB, Bour M, Beyrouthy R, Bonnet R, Laaberki MH, Charpentier X, Ruimy R, Plésiat P, Potron A. Genomic analysis of CTX-M-115 and OXA-23/-72 co-producing Acinetobacter baumannii, and their potential to spread resistance genes by natural transformation. J Antimicrob Chemother. 2022 May 29;77(6):1542-1552.
Godeux AS, Svedholm E, Barreto S, Potron A, Venner S, Charpentier X, Laaberki MH. Interbacterial transfer of carbapenem resistance and large antibiotic resistance islands by natural transformation in pathogenic Acinetobacter. mBio. 2022 Feb 22;13(1):e0263121. doi: 10.1128/mbio.02631-21. Epub 2022 Jan 25. Erratum in: mBio. 2022 Apr 26;13(2):e0052622.
Lombes A, Bonnin RA, Laurent F, Guet-Revillet H, Bille E, Cattoir V, Fangous MS, Le Brun C, Fihman V, Janvier F, Otto MP, Potron A, Corvec S, Ruffierd'Epenoux L, Mizrahi A, Dortet L; GMC Study Group. High Prevalence of OXA-23 Carbapenemase-Producing Proteus mirabilis among AmoxicillinClavulanate-Resistant Isolates in France. Antimicrob Agents Chemother. 2022 Feb 15;66(2):e0198321.
Robin B, Nicol M, Le H, Tahrioui A, Schaumann A, Vuillemenot JB, Vergoz D, Lesouhaitier O, Jouenne T, Hardouin J, Potron A, Perrot V, Dé E. MacAB-TolC contributes to the development of Acinetobacter baumannii biofilm at the solid-liquid interface. Front Microbiol. 2022 Jan 13;12:785161.
Job V, Gomez-Valero L, Renier A, Rusniok C, Bouillot S, Chenal-Francisque V, Gueguen E, Adrait A, 97 Robert-Genthon M, Jeannot K, Panchev P, Elsen S, Fauvarque MO, Couté Y, Buchrieser C, Attrée I. Genomic erosion and horizontal gene transfer shape functional differences of the ExlA toxin in Pseudomonas spp. iScience. 2022 Jun 14;25(7):104596.
Guerpillon B, Fangous MS, Le Breton E, Artus M, le Gall F, Khatchatourian L, Talarmin JP, Plesiat P, Jeannot K, Saidani N, Rolland-Jacob G. Elizabethkingia anophelis outbreak in France. Infect Dis Now. 2022 Aug;52(5):299-303.
Vu TH, Adhel E, Vielfort K, Ha Duong NT, Anquetin G, Jeannot K, Verbeke P, Hjalmar S, Gylfe Å, Serradji N. Modified Fluoroquinolones as Antimicrobial Compounds Targeting Chlamydia trachomatis. Int J Mol Sci. 2022 Jun 16;23(12):6741.
Elabbadi A, Pont S, Verdet C, Plésiat P, Cretin F, Voiriot G, Fartoukh M, Djibré M. An unusual community acquired invasive and multi systemic infection due to ExoU-harboring Pseudomonas aeruginosa strain: clinical disease and microbiological characteristics. J Microbiol Immunol Infect. 2020 Aug; 53(4):647-651.
Puja H, Bolard A, Noguès A, Plésiat P, Jeannot K. The efflux pump MexXY/OprM contributes to the tolerance and acquired resistance of Pseudomonas aeruginosa to colistin. Antimicrob Agents Chemother. 2020 Mar 24; 64(4):e02033-19.
Puja H, Comment G, Chassagne S, Plésiat P, Jeannot K. Coordinate overexpression of two RND efflux systems, ParXY and TtgABC, is responsible for multidrug resistance in Pseudomonas putida. Environ Microbiol. 2020, 10.1111/1462-2920.15200.
Roblin C, Chiumento S, Bornet O, Nouailler M, Müller CS, Jeannot K, Basset C, Kieffer-Jaquinod S, Couté Y, Torelli S, Le Pape L, Schünemann V, Olleik H, De La Villeon B, Sockeel P, Di Pasquale E, Nicoletti C, Vidal N, Poljak L, Iranzo O, Giardina T, Fons M, Devillard E, Polard P, Maresca M, Perrier J, Atta M, Guerlesquin F, Lafond M, Duarte V. The unusual structure of Ruminococcin C1 antimicrobial peptide confers clinical properties. Proc Natl Acad Sci U S A. 2020 Aug 11; 117(32):19168-19177.
Royer G, Fourreau F, Boulanger B, Mercier-Darty M, Ducellier D, Cizeau F, Potron A, Podglajen I, Mongardon N, Decousser JW. Local outbreak of extended- spectrum β-lactamase SHV2a-producing Pseudomonas aeruginosa reveals the emergence of a new specific sub-lineage of the international ST235 highrisk clone. J Hosp Infect. 2020 Jan; 104(1):33-39.
Michaut M, Steffen A, Contreras JM, Morice C, Paulen A, Schalk IJ, Plésiat P, Mislin GLA. Chryso-lactams: Gold (I) derivatives of ampicillin with specific activity against Gram-positive pathogens. Bioorg Med Chem Lett. 2020 May1; 30(9):127098.
Mack AR, Barnes MD, Taracila MA, Hujer AM, Hujer KM, Cabot G, Feldgarden M, Haft DH, Klimke W, van den Akker F, Vila AJ, Smania A, Haider S, Papp-Wallace KM, Bradford PA, Rossolini GM, Docquier JD, Frère JM, Galleni M, Hanson ND, Oliver A, Plésiat P, Poirel L, Nordmann P, Palzkill TG, Jacoby GA, Bush K, Bonomo RA. A standard numbering scheme for class C β-lactamases. Antimicrob Agents Chemother. 2020 Feb 21; 64(3):e01841-19.
Grosjean M, Guénard S, Giraud C, Muller C, Plésiat P, Juarez P. Targeted genome reduction of Pseudomonas aeruginosa strain PAO1 led to the development of hypovirulent and hypersusceptible rDNA Hosts. Front Bioeng Biotechnol. 2021 Mar 11; 9:640450.
Michaut M, Steffen A, Contreras JM, Morice C, Schalk IJ, Plésiat P, Mislin. GLA. 1,2,3-Triazole-gold(I)-triethylposphine derivatives active against resistant Gram-positive pathogens. Bioorg Med Chem Lett. 2021 Feb 24; 40:127879.
Gomez NO, Tetard A, Ouerdane L, Laffont C, Brutesco C, Ball G, Lobinski R, Denis Y, Plésiat P, Llanes C, Arnoux P, Voulhoux R. Involvement of the Pseudomonas aeruginosa MexAB-OprM efflux pump in the secretion of the metallophore pseudopaline. Mol Microbiol. 2021 Jan; 115(1):84-98.
Miltgen G, Bour M, Allyn J, Allou N, Vedani T, Vuillemenot JB, Triponney P, Martinet O, Lugagne N, BenoitCattin T, Dortet L, Birer A, Jaffar-Bandjee MC, Belmonte O, Plésiat P, Potron A. Molecular and epidemiological investigation of a colistin-resistant OXA-23-/NDM-1-producing Acinetobacter baumannii outbreak in the Southwest Indian Ocean Area. Int J Antimicrob Agents. 2021 Oct;58(4):106402. doi: 10.1016/j.ijantimicag.2021.106402. Epub 2021 Jul 19.
Grosjean M, Tazrout S, Bour M, Triponey P, Muller C, Jeannot K, Plésiat P. Reassessment of the cooperativity between efflux system MexAB-OprM and cephalosporinase AmpC in the resistance of Pseudomonas aeruginosa to β-lactams. J Antimicrob Chemother. 2021 Jan 19;76(2):536-539.
Fournier D, Carrière R, Bour M, Grisot E, Triponney P, Muller C, Lemoine J, Jeannot K, Plésiat P; GERPA Study Group. Mechanisms of resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa: Results of the GERPA Multicenter Study. Antimicrob Agents Chemother. 2021 Jan 20;65(2):e01117-20.
Jeannot K, Hagart K, Dortet L, Kostrzewa M, Filloux A, Plesiat P, Larrouy-Maumus G. Detection of Colistin Resistance in Pseudomonas aeruginosa using the MALDIxin test on the routine MALDI biotyper Sirius mass spectrometer. Front Microbiol. 2021 Aug 31;12:725383.
Daragon B, Fournier D, Plésiat P, Jeannot K. Performance of disc diffusion, MIC gradient tests and Vitek 2 for ceftolozane/tazobactam and ceftazidime/avibactam susceptibility testing of Pseudomonas aeruginosa. J Antimicrob Chemother. 2021 Sep 15;76(10):2586-2592.
Tetard A, Foley S, Mislin GLA, Brunel JM, Oliva E, Torrealba Anzola F, Zedet A, Cardey B, Pellequer Y, Ramseyer C, Plésiat P, Llanes C. Negative Impact of Citral on Susceptibility of Pseudomonas aeruginosa to Antibiotics. Front Microbiol. 2021 Jul 5;12:709838.
Grosjean M, Guénard S, Giraud C, Muller C, Plésiat P, Juarez P. Targeted Genome Reduction of Pseudomonas aeruginosa Strain PAO1 Led to the Development of Hypovirulent and Hypersusceptible rDNA Hosts. Front Bioeng Biotechnol. 2021 Mar 11;9:640450